Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Goodnoct 6.25mg Tablet XR

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Zolpidem (6.25mg)

Overview Goodnoct 6.25mg Tablet XR

Somnus 6.25mg Extended-Release Tablets are indicated for the short-term management of sleeplessness. They shorten the time it takes to fall asleep and lessen nighttime awakenings, promoting sustained sleep. Somnus 6.25mg Extended-Release Tablets should be ingested on an empty stomach, ideally just before bedtime. Consistent daily timing helps maintain therapeutic blood levels. Follow your physician's prescribed dosage and duration, as this medication can be habit-forming; do not discontinue use abruptly without consulting your doctor, as this could exacerbate symptoms. Potential side effects include impaired memory, visual disturbances, restlessness, headache, dizziness, gastrointestinal upset (diarrhea, nausea, vomiting), back pain, fatigue, and depression. While generally transient, persistent or bothersome effects necessitate medical attention. Somnus 6.25mg Extended-Release Tablets can induce drowsiness and dizziness; avoid driving or tasks requiring alertness until the medication's effects are known. Alcohol consumption should be avoided. Report any unusual mood shifts, new or worsening depression, hallucinations, or suicidal ideation to your doctor immediately. Before commencing treatment, disclose all other medications to your physician to ensure appropriate usage. Pre-existing liver or kidney conditions warrant medical consultation prior to starting Somnus 6.25mg Extended-Release Tablets. Smoking and alcohol should be avoided during treatment. This medication is contraindicated during pregnancy and breastfeeding; consult your physician if necessary.

Primary Ingredients of Goodnoct 6.25mg Tablet XR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Goodnoct 6.25mg Tablet XR

Managing Sleep Difficulties

Major Benefits of Goodnoct 6.25mg Tablet XR:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Goodnoct 6.25mg Extended-Release Tablet on an empty stomach.

Common Side effects of Goodnoct 6.25mg Tablet XR:

  • Dizziness
  • Sleepiness
  • Headache
  • Nausea
  • Stomach pain
  • Memory loss
  • Vertigo
  • Vomiting
  • Back pain
  • Agitation
  • Double vision
  • Depression

How to use Goodnoct 6.25mg Tablet XR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Administer Goodnoct 6.25mg Extended-Release Tablet on an empty stomach.

How Goodnoct 6.25mg Tablet XR works:

SomniRest 6.25mg Extended-Release Tablets are classified as non-benzodiazepine sleep aids. This medication exhibits hypnotic, sedative, and anticonvulsive effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter receptor, to reduce neuronal activity in the brain, thus promoting sleep onset.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Goodnoct 6.25mg extended-release tablets and alcohol can lead to significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Goodnoct 6.25mg tablets might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Goodnoct 6.25mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to infants.

DrivingDrivingUNSAFE

Extended-release Goodnoct 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Individuals with kidney disease can safely use Goodnoct 6.25mg extended-release tablets without a dosage modification. Nevertheless, disclosure of any kidney condition to your physician is advised.

LiverLiverCAUTION

Patients with liver impairment should use Goodnoct 6.25mg XR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should begin with a low Goodnoct 6.25mg XR tablet dosage; however, it's unsuitable for patients exhibiting severe hepatic dysfunction.

What if you forget to take Goodnoct 6.25mg Tablet XR :

Omit any missed Goodnoct 6.25mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Goodnoct 6.25mg Tablet XR

LabelValue
Chemical Type Imidazopyridine compound
Developing Habits Affirmative.
Treatment Category Central Nervous System (CNS) Neurobiology
Behavior Class Non-benzodiazepine sleeping medications (Z-drugs)

FAQs on Goodnoct 6.25mg Tablet XR

Goodnoct 6.25mg XR tablets promote relaxation and sleep. Some users may experience this as pleasant, even euphoric. However, long-term use can lead to dependence, making it difficult to sleep or function normally without the medication.
Goodnoct 6.25mg Tablet XR has potential for abuse, particularly among individuals with a history of substance abuse or addiction. Physicians should thoroughly assess patients for such history, and closely monitor those with a history of substance misuse during treatment.
Goodnoct 6.25mg XR tablets haven't shown drug interactions with prednisone. Nevertheless, always consult your doctor before combining them.
Goodnoct 6.25mg XR tablets treat insomnia; this may incidentally reduce anxiety in some users. However, it's not prescribed for anxiety because its mechanism differs from other anti-anxiety medications.
Goodnoct 6.25mg Tablet XR overdose can cause drowsiness, confusion, impaired coordination, muscle weakness, slowed or shallow breathing, and possibly coma.
Goodnoct 6.25mg XR tablets may cause daytime drowsiness and reduced alertness. Avoid driving or operating machinery until you understand how this medication affects you. Refrain from alcohol consumption while taking Goodnoct 6.25mg XR tablets, as it can worsen side effects.
Avoid Goodnoct 6.25mg Tablet XR if you're allergic to it, have a history of depression, mental illness, suicidal thoughts, drug or alcohol abuse, kidney or liver disease, lung disease, breathing problems, or are pregnant, planning pregnancy, or breastfeeding.
Avoid taking Goodnoct 6.25mg Tablet XR with or immediately after high-fat meals; its effectiveness may be reduced.
Goodnoct 6.25mg Extended-Release tablets treat short-term insomnia (difficulty sleeping) for 2 to 4 weeks. Always follow your doctor's instructions precisely; exceeding the prescribed dose or duration may cause dependence.
Dry mouth is a frequent side effect of Goodnoct 6.25mg Tablet XR, while weight gain is less common. Increased appetite may contribute to any weight gain experienced.
Goodnoct 6.25mg XR tablets induce sleepiness shortly after ingestion, an effect that may persist for several hours. Take this medication only if you can immediately go to bed and sleep for 7-8 uninterrupted hours. Avoid taking Goodnoct 6.25mg XR if you cannot maintain this sleep duration.
Always consult your doctor before discontinuing Goodnoct 6.25mg Tablet XR. Abrupt cessation may cause withdrawal, including discomfort, stomach and muscle cramps, vomiting, sweating, tremors, and in rare cases, seizures.
Enhance your sleep by avoiding caffeine and nicotine, particularly in the evening. Refrain from exercising within four hours of bedtime; while daily exercise promotes sleep, close-to-bedtime workouts can disrupt it. Avoid heavy evening meals and daytime naps. Maintain a consistent sleep-wake schedule. Keep your bedroom dark and comfortably cool. Dedicate time to relaxation before sleep, employing relaxation techniques.
Insomnia, a prevalent sleep disorder, is characterized by difficulty falling asleep, staying asleep, or both. Consequently, sufferers often experience insufficient or poor-quality sleep, leaving them unrefreshed upon waking.
Insomnia is categorized as primary or secondary. Primary insomnia has an unknown cause, often linked to lifestyle factors like prolonged stress and emotional distress. Secondary insomnia, conversely, arises from various sources including underlying medical conditions (e.g., depression, anxiety, PTSD, Alzheimer's, Parkinson's), medications, other sleep disorders, and substances (such as caffeine, nicotine, and alcohol).
Goodnoct 6.25mg Tablet XR
75
MRP 92
18% off